PD-L1 immunohistochemistry in non-small-cell lung cancer: unraveling differences in staining concordance and interpretation

Programmed death ligand 1 (PD-L1) immunohistochemistry (IHC) is accepted as a predictive biomarker for the selection of immune checkpoint inhibitors. We evaluated the staining quality and estimation of the tumor proportion score (TPS) in non-small-cell lung cancer during two external quality assessm...

Descripción completa

Detalles Bibliográficos
Autores principales: Keppens, Cleo, Dequeker, Elisabeth MC, Pauwels, Patrick, Ryska, Ales, ‘t Hart, Nils, von der Thüsen, Jan H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099807/
https://www.ncbi.nlm.nih.gov/pubmed/33275169
http://dx.doi.org/10.1007/s00428-020-02976-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099807/
https://www.ncbi.nlm.nih.gov/pubmed/33275169
http://dx.doi.org/10.1007/s00428-020-02976-5

Ejemplares similares